Shenzhen Hybio Pharmaceutical: difference between revisions
Diff·revision 5 → 6·00:06, 3 Sep 2025
Difference between revision 5 and revision 6 of Shenzhen Hybio Pharmaceutical. 3 lines changed; the page grew by 696 bytes.
| Revision 5 — 18:30, 28 Aug 2025 DrTitration (talk) add the see-also to the certificate-of-analysis article 2,845 bytes ±0 | Revision 6 — 00:06, 3 Sep 2025 PriorAuthPaz (talk) space between number and unit per PP:MOS 3,541 bytes +696 | ||
|---|---|---|---|
| 10 | The organisation is one of twenty-two covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} | 10 | The organisation is one of twenty-two covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} |
| 11 | 11 | ||
| + | 12 | This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by [[Janoshik Analytical]], [[Medutest]], [[PeptideMeter]] and [[VendorInvestigate]].{{r|tally}} | |
| + | 13 | ||
| 12 | == Corporate identity and history == | 14 | == Corporate identity and history == |
| 13 | Incorporated in Shenzhen in 2003, the organisation sits with the earlier incorporation dates among the entities covered on this wiki and predates the current research-peptide market by roughly a decade.{{r|registry}} Shenzhen is inside the Pearl River Delta manufacturing belt, and the organisation's own material describes a business built on peptide [[Active pharmaceutical ingredient|active pharmaceutical ingredient]] supply and contract development rather than on catalogue distribution alone.{{r|selfpub}} | 15 | Incorporated in Shenzhen in 2003, the organisation sits with the earlier incorporation dates among the entities covered on this wiki and predates the current research-peptide market by roughly a decade.{{r|registry}} Shenzhen is inside the Pearl River Delta manufacturing belt, and the organisation's own material describes a business built on peptide [[Active pharmaceutical ingredient|active pharmaceutical ingredient]] supply and contract development rather than on catalogue distribution alone.{{r|selfpub}} |
| ⋮ | ⋮ | ||
| 19 | <ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref> | 21 | <ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref> |
| 20 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> | 22 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> |
| + | 23 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | |
| 21 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 24 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 22 | 25 |